Compound Summary
aminoglutethimide
Compound Information
aminoglutethimide
Compound Name: | aminoglutethimide |
Compound CID: | 2145 |
Synonyms: | aminoglutethimide 125-84-8 dl-Aminoglutethimide Cytadren Orimeten More... |
Iupac Name: | 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione |
InChI: | InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17) |
InChIKey: | ROBVIMPUHSLWNV-UHFFFAOYSA-N |
Canonical Smiles: | CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N |
Isomeric Smiles: | CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N |
Molecular Weight: | 232.28 |
Molecular Formula: | C13H16N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
aminoglutethimide
Molecular Weight: | 232.28 |
Molecular Formula: | C13H16N2O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 17 |
Complexity: | 321 |
Synonyms
aminoglutethimide
| aminoglutethimide | aminoglutethimide |
|---|---|
aminoglutethimide |
125-84-8 |
dl-Aminoglutethimide |
Cytadren |
Orimeten |
p-Aminoglutethimide |
Elipten |
3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione |
3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione |
2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl- |
Aminoglutetimida |
Aminoglutethimidum |
2-(p-Aminophenyl)-2-ethylglutarimide |
Ba-16038 |
3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine |
(+/-)-p-AMINOGLUTETHIMIDE |
Glutethimide, para-amino |
Glutarimide, 2-(p-aminophenyl)-2-ethyl- |
AG-1 |
MFCD00010122 |
3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione |
CHEMBL488 |
NSC-330915 |
CHEBI:2654 |
alpha-(p-Aminophenyl)-alpha-ethylglutarimide |
DSSTox_CID_2589 |
DSSTox_RID_76647 |
.alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide |
DSSTox_GSID_22589 |
(RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide;(RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine |
Aminoglutethimidum INN-Latin |
Aminoglutetimida INN-Spanish |
Aminoglutetimide |
Ba 16038 |
Cytadren (TN) |
SMR000326785 |
C 16038-BA |
CCRIS 7562 |
aminoglutethimide (AG) |
SR-01000075596 |
3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion |
EINECS 204-756-4 |
BRN 0210656 |
Aminoglutethimide (USP/INN) |
HSDB 7494 |
3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione |
Aminoglutethimide USP:INN:BAN |
NCGC00016379-01 |
CAS-125-84-8 |
Prestwick_243 |
Spectrum_000040 |
(y)-p-Aminoglutethimide |
Aminoglutethimide AG, 4 |
Aminoglutethimide- Bio-X |
(?)-p-Aminoglutethimide |
Prestwick0_000244 |
Prestwick1_000244 |
Prestwick2_000244 |
Prestwick3_000244 |
Spectrum2_000093 |
Spectrum3_000296 |
Spectrum4_000144 |
Spectrum5_000802 |
3-Carboxy-1,1-dimethyl-, (E)-2-propenyl |
A 9657 |
SCHEMBL4306 |
Aminoglutethimide (Cytadren) |
Lopac0_000124 |
BSPBio_000028 |
BSPBio_001832 |
KBioGR_000588 |
KBioSS_000400 |
(A+/-)-p-Aminoglutethimide |
MLS000859924 |
MLS001213216 |
DivK1c_000884 |
SPECTRUM1500115 |
SPBio_000046 |
SPBio_002247 |
BDBM9460 |
BPBio1_000032 |
GTPL7054 |
DTXSID8022589 |
HMS502M06 |
KBio1_000884 |
KBio2_000400 |
KBio2_002968 |
KBio2_005536 |
KBio3_001332 |
NINDS_000884 |
HMS1568B10 |
HMS1920C09 |
HMS2090I05 |
HMS2091I09 |
HMS2095B10 |
HMS2231M19 |
HMS3259H10 |
HMS3260I10 |
HMS3372M07 |
HMS3655O17 |
HMS3712B10 |
Pharmakon1600-01500115 |
57288-03-6 |
AMY33415 |
BCP28501 |
EBD40055 |
HY-B0237 |
2, 3-(4-aminophenyl)-3-ethyl- |
Tox21_110406 |
Tox21_303497 |
Tox21_500124 |
BBL010961 |
CCG-38911 |
NSC330915 |
NSC755868 |
SBB000711 |
STK802074 |
2-(4-aminophenyl)-2-ethylglutarimide |
AKOS004120070 |
AKOS022060651 |
Tox21_110406_1 |
AT-2947 |
DB00357 |
LP00124 |
MCULE-9118268281 |
NC00714 |
NSC 330915 |
NSC 755868 |
NSC-755868 |
SDCCGSBI-0050112.P005 |
IDI1_000884 |
SMP1_000017 |
NCGC00015110-02 |
NCGC00015110-03 |
NCGC00015110-04 |
NCGC00015110-05 |
NCGC00015110-06 |
NCGC00015110-07 |
NCGC00015110-09 |
NCGC00015110-12 |
NCGC00015110-21 |
NCGC00093615-01 |
NCGC00093615-02 |
NCGC00093615-03 |
NCGC00093615-04 |
NCGC00093615-05 |
NCGC00257263-01 |
NCGC00260809-01 |
AC-12456 |
AS-13282 |
BA164155 |
H801 |
NCI60_002900 |
SBI-0050112.P004 |
AB0013271 |
DB-021640 |
DB-072002 |
DB-072275 |
AB00051935 |
EU-0100124 |
FT-0773944 |
S1672 |
SW196550-3 |
( inverted question mark)-p-Aminoglutethimide |
EN300-53368 |
VU0243029-3 |
C07617 |
D00574 |
D88489 |
AB00051935-09 |
AB00051935-11 |
AB00051935_12 |
AB00051935_13 |
125A848 |
A805433 |
Q241150 |
3-(4-aminophenyl)-3-ethylazaperhydroine-2,6-dione |
SR-01000075596-1 |
SR-01000075596-4 |
SR-01000075596-6 |
W-108399 |
BRD-A25234499-001-05-0 |
BRD-A25234499-001-09-2 |
Z1259341083 |
Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard |
Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
aminoglutethimide
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 17.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
aminoglutethimide
Statistics Data
aminoglutethimide
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 17.000000000000000 | 1 | 1 |
Statistics Data Visualization
aminoglutethimide
